Key legislators
Who's moving medicaid in Washington
Showing 51–53 of 53
bills
All healthcare bills
HB 1502 establishes a new "behavioral health teaching clinic" designation for licensed or certified behavioral health agencies that train interns and new graduates in mental health and substance use care. To qualify, agencies must meet specific standards, including providing clinical supervision, equitable access to services, and formal partnerships with educational institutions. Designated clinics will receive an enhanced reimbursement rate to offset the costs of training (currently unpaid), helping them retain staff and address workforce shortages. This policy directly affects community behavioral health agencies serving Medicaid patients, which face high turnover due to low reimbursement rates and competition from other healthcare settings.
Senate Bill 5124 aims to increase patient access to timely and medically necessary postacute care for Medicaid enrollees in Washington state. It directs the state's Health Care Authority to establish network adequacy standards for skilled nursing facilities and rehabilitation hospitals by January 1, 2027. These standards will ensure care remains local and timely, considering factors like geographic availability and provider presence within regional service areas. The Authority is required to obtain feedback from various healthcare stakeholders, including hospitals and managed care organizations, during the development of these standards, which will then be incorporated into managed care contracts.
HB 1425 requires Washington health insurance plans (including Medicaid) to cover genetic testing that helps match patients with effective mental health medications, starting January 1, 2026. Insurers cannot require prior authorization or force patients to try ineffective medications first. Coverage must include tests approved by the FDA or supported by clinical guidelines and research evidence. This applies specifically to psychotropic medications prescribed for conditions like depression, aiming to reduce the trial-and-error process that leaves many patients without relief.
